trioxbio firm

TrioxBio is an innovative biotech company, developing novel drugs based on inhibition Nitric Oxide. The company focuses on orphan indications for Migraine, Cardio vascular and Dialysis treatment. Our company believes it is developing promising new NOS inhibitors, to date having 2 ongoing clinical FDA trials in phase II . The company holds a substantial clinical database , collected from 420 patients. The leading candidate is a migraine small molecule tablet for the treatment of acute migraine showing superior safety and efficacy results in clinical trials compare to the current standard of care. Triox Bio is a development stage biotechnology company focused on bringing to market new products and new delivery systems to existing products.

SK-PHARMA Group

Garan SK

Garan S.K., a subsidiary of K.S. Kim, is, like its parent company, is involved in the registration and marketing of pharmaceuticals, but in the larger CIS area. The entire range of marketing needs of the pharmaceutical products under our care are seen to by the company, with services ranging from the initial launch of the product in the market place, registration legalities, marketing program design and promotional strategies, to end-phase logistics and distribution.Extensive resources are invested toward encouraging cooperation and leadership, leading to a positive outcome for our combined business ventures.

KS-Kim group

KS Kim International is SK Pharma’s international marketing group for innovative and generic healthcare and pharmaceutical solutions.

gfbiotech

GF Bio, LLC. is a development stage biopharmaceutical company focused on bringing innovative medicines which have already been marketed in developing countries to the US market.

Go Top